QCG
DXCM icon

Quadrant Capital Group’s DexCom DXCM Stock Holding History

Quadrant Capital Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$855K Buy
13,614
+2,181
+19% +$152K 0.03% 637
2025
Q4 		$759K Buy
11,433
+8,350
+271% +$540K 0.02% 696
2025
Q3 		$207K Sell
3,083
-6,500
-68% -$514K 0.01% 1264
2025
Q2 		$837K Buy
9,583
+2,437
+34% +$191K 0.03% 574
2025
Q1 		$488K Buy
7,146
+3,933
+122% +$321K 0.02% 758
2024
Q4 		$250K Buy
3,213
+289
+10% +$21.4K 0.02% 567
2024
Q3 		$196K Sell
2,924
-2,579
-47% -$212K 0.01% 706
2024
Q2 		$624K Buy
5,503
+126
+2% +$15.9K 0.05% 275
2024
Q1 		$746K Buy
5,377
+950
+21% +$119K 0.06% 237
2023
Q4 		$549K Buy
4,427
+827
+23% +$84.5K 0.05% 281
2023
Q3 		$336K Sell
3,600
-366
-9% -$41.3K 0.03% 361
2023
Q2 		$510K Sell
3,966
-131
-3% -$15.8K 0.05% 251
2023
Q1 		$476K Buy
4,097
+53
+1% +$5.93K 0.05% 280
2022
Q4 		$458K Buy
4,044
+792
+24% +$87K 0.05% 258
2022
Q3 		$262K Buy
3,252
+1,428
+78% +$121K 0.03% 347
2022
Q2 		$136K Sell
1,824
-564
-24% -$51.5K 0.02% 537
2022
Q1 		$306K Buy
2,388
+144
+6% +$15.8K 0.04% 344
2021
Q4 		$301K Buy
2,244
+116
+5% +$16.7K 0.04% 336
2021
Q3 		$291K Buy
2,128
+204
+11% +$25.7K 0.04% 300
2021
Q2 		$205K Buy
1,924
+320
+20% +$30.7K 0.03% 376
2021
Q1 		$144K Buy
1,604
+260
+19% +$24.4K 0.02% 444
2020
Q4 		$124K Sell
1,344
-324
-19% -$28.9K 0.02% 427
2020
Q3 		$172K Sell
1,668
-132
-7% -$13.8K 0.04% 291
2020
Q2 		$182K Sell
1,800
-1,076
-37% -$96.3K 0.04% 285
2020
Q1 		$194K Buy
2,876
+332
+13% +$20.7K 0.03% 383
2019
Q4 		$138K Buy
2,544
+20
+0.8% +$949 0.02% 818
2019
Q3 		$93K Hold
2,524
– – 0.01% 910
2019
Q2 		$94K Hold
2,524
– – 0.01% 888
2019
Q1 		$73K Buy
2,524
+1,796
+247% +$63.1K 0.01% 979
2018
Q4 		$21K Hold
728
– – 0.01% 1168
2018
Q3 		$25K Hold
728
– – 0.01% 887
2018
Q2 		$16K Hold
728
– – 0.01% 1054
2018
Q1 		$12K Hold
728
– – ﹤0.01% 1175
2017
Q4 		$9K Buy
728
+408
+128% +$5.3K ﹤0.01% 1215
2017
Q3 		$3K Sell
320
-684
-68% -$12.1K ﹤0.01% 1640
2017
Q2 		$12K Buy
1,004
+812
+423% +$15K 0.01% 1048
2017
Q1 		$4K Sell
192
-532
-73% -$10.4K ﹤0.01% 1401
2016
Q4 		$9K Sell
724
-12
-2% -$213 ﹤0.01% 1054
2016
Q3 		$15K Hold
736
– – 0.01% 873
2016
Q2 		$13K Hold
736
– – 0.01% 890
2016
Q1 		$12K Sell
736
-452
-38% -$7.55K 0.01% 863
2015
Q4 		$24K Buy
1,188
+52
+5% +$1.08K 0.02% 521
2015
Q3 		$23K Buy
1,136
+824
+264% +$18.4K 0.02% 566
2015
Q2 		$6K Buy
+312
New +$5.48K ﹤0.01% 801

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Quadrant Capital Group's DXCM Position: Q1 2026 in Review

Quadrant Capital Group increased its DexCom (DXCM) stake by 19% in Q1 2026, buying an estimated $152K and bringing the position to 13,614 shares worth $855K. The position accounts for 0.03% of the portfolio, ranked #637.

Quadrant Capital Group first reported a position in DXCM in Q2 2015 and has held it in 44 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Quadrant Capital Group held 13,614 shares of DexCom worth $855K as of Q1 2026.
  • Quadrant Capital Group bought 2,181 DexCom shares in Q1 2026, an estimated $152K.
  • DexCom made up 0.03% of Quadrant Capital Group's portfolio in Q1 2026, its #637 holding.
  • Quadrant Capital Group first reported a position in DexCom in Q2 2015 and has held it in 44 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.